Results

Total Results: 1,034 records

Showing results for "drugs".

121. Archived: Evidence Summary: Aspirin: Aspirin/NSAIDs for Prevention of Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-aspirin/aspirin-nsaids-for-prevention-of-colorectal-cancer-preventive-medication-2007
     March 15, 2007 - have suggested a protective effect of aspirin as well as nonaspirin nonsteroidal anti-inflammatory drugs … Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. … Effect of aspirin and nonsteroidal anti-inflammatory drugs on colorectal adenomas: case-control study … Long-term use of nonsteroidal antiinflammatory drugs and the risk of colorectal adenomas. … Drugs and colon cancer. Pharmacoepidemiol Drug Saf 1998;7:99-106.

122. Screening for Chlamydia and Gonorrhea (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFileByID/1880
     September 01, 2014 - Not using condoms consistently and exchanging sex for money or drugs also increases a person’s risk … Not using condoms consistently and exchanging sex for money or drugs also can increase your risk.

123. Screening for Chlamydia and Gonorrhea (pdf file)
     www.uspreventiveservicestaskforce.org/Home/GetFileByToken/qt3Ekxo_UpRrZ54HYAoW_G
     September 01, 2014 - Not using condoms consistently and exchanging sex for money or drugs also increases a person’s risk … Not using condoms consistently and exchanging sex for money or drugs also can increase your risk.

124. PII: S0749-3797(01)00255-0 (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/yw_rbA_nQrCnkaN8X5t56S
     January 01, 2001 - published after 1995 and used hepatic 3-methylglutaryl coenzyme A reductase inhibitors or “statin” drugs … The two trials employing statin drugs (WOSCOPS and AFCAPS) had larger initial decreases in TC (20% and … Statin drugs have produced larger reductions in cholesterol and appear to reduce events more than the … older drugs. … Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized

125. Nz Rqwxmmr8Vym-Yjuqru- (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/NZ_RQWxMMR8Vym-yJuqru-
     May 23, 2019 - The trials used various antihypertensive drugs. … Hypertensive per- sons taking calcium antagonists compared with those tak- ing other drugs may have a … Some evidence suggests that, compared with most other antihypertensive drugs, ACE inhibitors or ARBs … Second, the meta-analyses grouped specific drugs within a class together. … Drugs within a class, however, may have different effects.

126. Archived: Evidence Summary: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening, 2001 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2001
     April 09, 2001 - published after 1995 and used hepatic 3-methylglutaryl coenzyme A reductase inhibitors or “statin” drugs … The two trials employing statin drugs (WOSCOPS and AFCAPS) had larger initial decreases in TC (20% and … Statin drugs have produced larger reductions in cholesterol and appear to reduce events more than the … older drugs. … Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized

127. Archived: Final Evidence Review: Hepatitis C: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review49/hepatitis-c-screening-2013
     November 15, 2012 - blood transfusion, rejections as a blood donor, refused life insurance, witnessed use of injecting drugs … (self-report) C: Ever injected drugs or blood transfusions before 1992 (self-report) D: Same … as C, or sex partner used injection drugs (self-report) E: Same as D (self-report or identified … : 38% Back 1960–1969: 18% Female: 58% Nonwhite: 37% Reports seeing use of injecting drugs … during transfusion, rejection as a blood donor, refused life insurance, witnessing use of injecting drugs

128. Archived: Final Research Plan: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan23/hepatitis-b-virus-infection-screening-may-2014
     March 15, 2013 - clearance  <3 months followup data; drug resistance; development of mutations or antibodies to drugs

129. Draft Research Plan: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
     May 23, 2019 - defined as three or more vitamins, minerals, or combinations of both without added herbs, hormones, or drugs

130. Final Research Plan: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/statin-use-in-adults-preventive-medication
     November 05, 2020 - with a prior CVD-related event or familial hyperlipidemia Interventions Statin therapy Other drugs

131. Archived: Human Immunodeficiency Virus (HIV) Infection: Screening, 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screeni
     July 05, 2005 - multiple partners; past or present injection drug users; men and women who exchange sex for money or drugs … with increased risky behaviors in individuals known to be seropositive. 34 , 35 All antiretroviral drugs … other fetal harm have been associated with in utero exposure to FDA-approved regimens of antiretroviral drugs … as 6 years, no studies have evaluated the effects of limited exposure to combination antiretroviral drugs … Recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health

132. Archived: Human Immunodeficiency Virus (HIV) Infection: Screening, 2005 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening-2005
     July 05, 2005 - multiple partners; past or present injection drug users; men and women who exchange sex for money or drugs … with increased risky behaviors in individuals known to be seropositive. 34 , 35 All antiretroviral drugs … other fetal harm have been associated with in utero exposure to FDA-approved regimens of antiretroviral drugs … as 6 years, no studies have evaluated the effects of limited exposure to combination antiretroviral drugs … Recommendations for use of antiretroviral drugs in pregnant HIV-1 infected women for maternal health

133. Archived: Final Research Plan: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan23/hepatitis-b-virus-infection-screening-nonpregnant-adolescents-adults-may-2014
     March 15, 2013 - clearance  <3 months followup data; drug resistance; development of mutations or antibodies to drugs

134. Screening for Hepatitis C Virus Infection in Adults: A Systematic Review for the USPSTF (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/ZrLh7o2TpPpY9WXXWbXbGk
     January 01, 2013 - : 4.6% Female: Not reported Self-reported injection drug use: 5.7% A: Screen all B: Ever injected drugs … (self-report) C: Ever injected drugs or blood transfusions before 1992 (self-report) D: Same as C, … or sex partner used injection drugs (self-report) E: Same as D (self-report or identified by clinic … Born 1950–1959: 38% Back 1960–1969: 18% Female: 58% Nonwhite: 37% Reports seeing use of injecting drugs … during transfusion, rejection as a blood donor, refused life insurance, witnessing use of injection drugs

135. Archived: Evidence Summary: Diabetes Mellitus (Type 2) in Adults: Screening, 2003 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/diabetes-mellitus-type-2-in-adults-screening-2003
     February 03, 2003 - The trials used various antihypertensive drugs. … Hypertensive persons taking calcium antagonists compared with those taking other drugs may have a somewhat … a single drug to attain their target blood pressures, making head-to-head comparisons of particular drugs … Second, the meta-analyses grouped specific drugs within a class together. … Drugs within a class, however, may have different effects.

136. Archived: Lipid Disorders in Adults (Cholesterol, Dyslipidemia): Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-adults-cholesterol-dyslipidemia-screening-2008
     December 30, 2013 - most patients, a minority achieves substantial reductions in lipid levels from changes in diet alone; drugs … The risk for total mortality was not lower in women treated with lipid-lowering drugs, regardless of … There is limited evidence about primary prevention of coronary heart disease using drugs in older populations … Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomized

137. U.S. Preventive Services Task Force Issues Final Recommendation on Screening for Syphilis Infection (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/syphilis-nonpregnant-adults-adolescents-screening-final-rec-bulletin.pdf
     September 27, 2022 - higher in men who have sex with men; people with HIV infection or other STIs; people who use illicit drugs

138. Archived: Evidence Summary: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary29/hepatitis-b-virus-infection-screening-may-2014
     May 27, 2014 - Results were generally consistent across individual drugs, although some estimates were imprecise and … The figure shows that pooling results across drugs from the 7 individual studies results in a relative … The figure shows that pooling results across drugs from the 9 individual studies results in a relative … Results were generally consistent across specific antiviral drugs. … Results were generally consistent across specific antiviral drugs.

139. Archived: Evidence Summary: Hepatitis B Virus Infection: Screening, 2014 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary29/hepatitis-b-virus-infection-screening-nonpregnant-adolescents-adults-may-2014
     May 27, 2014 - Results were generally consistent across individual drugs, although some estimates were imprecise and … The figure shows that pooling results across drugs from the 7 individual studies results in a relative … The figure shows that pooling results across drugs from the 9 individual studies results in a relative … Results were generally consistent across specific antiviral drugs. … Results were generally consistent across specific antiviral drugs.

140. Archived: Aspirin for the Prevention of Cardiovascular Disease: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication
     March 15, 2009 - HDL = high-density lipoprotein, MI = myocardial infarction, NSAIDs = nonsteroidal anti-inflammatory drugs … Figure 2 were developed assuming that the men are not currently taking nonsteroidal anti-inflammatory drugs … HDL = high-density lipoprotein, MI = myocardial infarction, NSAIDs = nonsteroidal anti-inflammatory drugs … for GI bleeding increases with age and that the women are not taking nonsteroidal anti-inflammatory drugs … Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP